Shamburg News · 8-K filed Nov 17, 2026, 4:33 PM EST

CytoDyn Appoints Lauren Wilcoxen as Chief Operating Officer and Head of Regulatory Affairs

CYDY · CytoDyn Inc.

  • Leadership change
  • Material agreement
  • Reg FD disclosure
  • Materiality: high

On November 17, 2026, CytoDyn Inc. entered into an employment agreement with Lauren Wilcoxen, Ph.D., under which she will serve as Chief Operating Officer and Head of Regulatory Affairs effective November 20, 2026, following Board approval on November 12, 2026. Her initial compensation includes an annual base salary of $425,000, a target annual bonus of 40% of base salary for the fiscal year ending May 31, 2027, and a nonqualified stock option to purchase 4,500,000 shares vesting over four years. The company also furnished a press release dated November 17, 2026 announcing the appointment as Exhibit 99.1.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 5.02, 7.01, 9.01, accession 0001175680-26-000042.

Written from the filing by Shamburg Markets. Figures are as reported by the company.